Expression of the active form of MMP-2 on the surface of leukemic cells accounts for their in vitro invasion

Journal of Cancer Research and Clinical Oncology

Volumn 124, Issue 5, 1998, Pages 245-252

  Sawicki, Grzegorz ^a,b   Matsuzaki, Akinobu ^a   Janowska Wieczorek, Anna ^a  

^a Canadian Red Cross Society   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

AML; Matrigel assay; MMP 2; MMP 9; MT MMP

Indexed keywords

GELATINASE A; GELATINASE B; MATRIGEL; MONOCLONAL ANTIBODY; PHORBOL 13 ACETATE 12 MYRISTATE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BLAST CELL; CANCER INVASION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BLOTTING, WESTERN; COLLAGENASES; ELECTROPHORESIS; FLOW CYTOMETRY; GELATINASES; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MEMBRANE PROTEINS; METALLOENDOPEPTIDASES; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; TUMOR CELLS, CULTURED;

EID: 0031800908     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050161     Document Type: Article

References (32)

1. Azzam HS, Arand G, Lippman ME, Thompson EW (1993) Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production. J Natl Cancer Inst 85:1758-1764
2. Brooks PC, Stromblad S, Sanders LG, Schalscha TL, Aimes RT, Stetler-Stevenson WG, Quigley JP, Cheresh DA (1996) Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrins αvβ3. Cell 85:683-693
3. Cao J, Sato H, Takino T, Seiki M (1995) The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation. J Biol Chem 270:801-805
4. r 94,000 gelatin-degrading metalloprotease induced during differentiation of HL-60 promyelocyctic leukemia cells: a member of the collagenase family of enzymes. Cancer Res 50:1113-1120
5. r 72,000 type IV collagenase. Cancer Res 52:5845-5848
6. Goetzl EJ, Banda MJ, Leppert D (1996) Matrix metalloproteinases in immunity. J Immunol 156:1-4
7. Heussen C, Dowdle EB (1980) Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Ann Biochem 102:196-202
8. Janiak M, Hashmi H, Janowska-Wieczorek A (1994) Use of the Matrigel-based assay to measure the invasiveness of leukemic cells. Exp Hematol 22:559-565
9. Kawamata H, Kawai K, Kamayama S, Johnson MD (1995) Overexpression of tissue inhibitor of matrix metalloproteinases (TIMP-1 and TIMP-2) suppresses extravasation of pulmonary metastasis of a rat bladder carcinoma. Int J Cancer 63:680-687
10. Kinoshita T, Sato H, Takino T, Itoh M (1996) Processing of a precursor of 72-kilodalton type IV collagenase gelatinase A by a recombinant membrane-type 1 metalloproteinase. Cancer Res 56:2535-2538
11. Kleiner DE Jr, Tuhila A, Tryggvason K, Stetler-Stevenson WG (1993) Stability analysis of latent and active 72 kDa type IV collagenase: the role of tissue inhibitor of metalloproteinases-2 (TIMP-2). Biochemistry 32:1583-1592
12. Kleinman HK, McGarvey ML, Liotta LA, Robey PG, Tryggvason K, Martin GR (1982) Isolation and characterization of type IV procollagen, laminin and heparan sulphate proteoglycan from the EHS sarcoma. Biochemistry 21:6188
13. Kossakowska AE, Urbanski SJ, Huchcroft SA, Edwards DR (1992) Relationship between the clinical aggressiveness of large cell immunoblastic lymphomas and expression of 92 kDa gelatinase (type IV collagenase) and tissue inhibitor of metalloproteinase-1 (TIMP-1) RNAs. Oncol Res 4:233-240
14. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head bacteriophage T4. Nature 227:680-685
15. Leppert D, Waubant E, Galardy R, Bunnet NW, Hauser SL (1995) T cell gelatinases mediate basement membrane transmigration in vitro. J. Immunol 154:4379-4389
16. Matsuzaki A, Janowska-Wieczorek A (1997) Unstimulated human acute myelogenous leukemia blasts secrete matrix metalloproteinases. J Cancer Res Clin Oncol 123:100-106
17. Mignatti P, Rifkin DB (1993) Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 73:161-195
18. r 72,000 matrix metalloproteinase at cell surface invadopodia. Cancer Res 53:3159-3164
19. Morodomi T, Ogata Y, Sasaguri Y, Morimatsu M, Nagase H (1992) Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT 1080 fibrosarcoma cells. Biochem J 285:603-613
20. Murphy G, Reynolds JL (1993) Extracellular matrix degradation. In: Connective tissue and its heritable disorders. Wiley-Liss, New York, pp 287-316
21. Nabeshima K, Komada N, Kishi J, Koita H, Inoue T, Hayakawa T (1993) TPA-enhanced invasion of Matrigel associated with augmentation of cell motility but not metalloproteinase activity in a highly metastatic variant (L-10) of human rectal adenocarcinoma cell line RCM-1. Int J Cancer 55:974-981
22. Naylor MS, Stamp GW, Davies BD, Balkwill FR (1994) Expression and activity of MMPs and their regulators in ovarian cancer. Int J Cancer 58:50-96
23. Ries C, Kolb H, Petrides PE (1994) Regulation of 92-kD gelatinase release in HL-60 leukemia cells: tumor necrosis factor-α as an autocrine stimulus for basal- and phorbol ester-induced secretion. Blood 83:3638-3646
24. Rutka JT, Matsuzawa K, Hubbard SL, Fukuyama K, Becker LE. Stetler-Stevenson WG, Edwards DR, Dirks PB (1995) Expression of TIMP-1, TIMP-2, 72 and 92 kDa type IV collagenase transcripts in human astrocytoma cell lines: correlation with astrocytoma cell invasiveness. Int J Oncol 6:877-884
25. Sato H, Seiki M (1996) Membrane-type matrix metalloproteinase (MT-MMPs) in tumor metastasis. J Biochem (Tokyo) 119:209-215
26. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki MA (1994) Matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370: 61-65
27. Stetler-Stevenson WG (1990) Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev 9:289-303
28. Stetler-Stevenson WG, Hewitt L, Corcoran M (1996) Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic. Semin Cancer Biol 7:147-154
29. Stetler-Stevenson M, Mansoor A, Lim M, Fukushima P, Kehrl J, Marti G, Ptaszynski K, Wang J, Stetler-Stevenson WG (1997) Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in reactive and neoplastic lymphoid cells. Blood 89:1708-1715
30. Watanahe H, Nukanishi I, Yamashita K, Kayakavva T, Okada Y (1993) Matrix metalloproteinase-9 (92 kDa gelatinase type IV collagenase) from U937 monoblastoid cells: correlation with cellular invasion. J Cell Sci 104:991-999
31. Whitelock JM, O'Grady LR, Gibbins JR (1991) Interstitial collagenase (matrix metalloproteinase 1) associated with the plasma membrane of both neoplastic and nonneoplastic cells. Invasion Metastasis 11:139-148
32. Zeng ZS, Guillem JG (1995) Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase I mRNA expression in human colorectal cancer and liver metastases. Br J Cancer 72:575-582